A 20-week, Multi-centre, Open-labelled, Non-comparative evaluation of the Safety and Efficacy of Insulin Detemir in Combination with OAD in Subjects with Type 2 Diabetes Inadequately Controlled on Current Therapy Phase 3 B-Clinical Trial, Trial ID: NN304-1569 (one of the five centres in the world).

Evaluation of efficiency and safety of a fixed dose combination of MetforminXL+ Glipizide XL Vs a fixed dose combination of Metformin+ Glipizide for control of Hyperglycemia in patients with Type2 Diabetes Mellitus.(2003).